Following publication of this article [1], concerns were raised regarding the presented data.
In Figure 5, the P-JAK1 and STAT3 Western blot panels are duplicates.
Four pairs of panels are duplicated in Figure 7:
1. 7A panels CD86 and OX62.
2. 7B panels CD86 and OX62.
3. 7A panel CD11b/c and 7C panel CD11b/c.
4. 7A panel MHC-II and 7B panel CD80.
Three pairs of panels are duplicated between Figure 7 and Figure 2:
1. 7B panel CD86 and 2A panel CD86.
2. 7D panel CD11b/c and 2A panel CD11b/c.
3. 7E panel CD11b/c and 2B panel CD11b/c.
Concerns were raised regarding the accuracy of the percentage data presented for region M2 of the erroneously duplicated FACS plots.
Two pairs of panels are duplicated in Figure 8:
1. Figure 8A: P-JAK1 and JAK1 Western blot panels.
2. Figure 8C: STAT3 and P-STAT3 Western blot panels.
Uncropped, raw blot images are no longer available for further evaluation.
In view of the concerns regarding the reliability of the results and the absence of the raw data images, the authors and PLOS ONE Editors retract this article. The authors wish to apologize to readers.
WHL, JW, LLZ, LY, MMZ and BY agree with the retraction. JJL, and FL could not be reached.
1. Liu W-h, Liu J-j, Wu J, Zhang L-l, Liu F, Yin L, et al. (2013) Novel Mechanism of Inhibition of Dendritic Cells Maturation by Mesenchymal Stem Cells via Interleukin-10 and the JAK1/STAT3 Signaling Pathway. PLoS ONE 8(1): e55487. pmid:23383203
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© 2018 Liu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.